Similar articles for PMID: 28743036

Year	Number of Results
1960	1
2008	2
2009	2
2010	3
2011	6
2012	8
2013	5
2014	8
2015	15
2016	14
2017	11
2018	3
2019	3
2020	2
2021	1
2022	5
2024	0

1

RECIST response and variation of circulating tumour cells in phase 1 trials: A prospective multicentric study.

Massard C, Borget I, Farace F, Aspeslagh S, Le Deley MC, Le Tourneau C, Bidard FC, Pierga JY, Dieras V, Hofman P, Spano JP, Ferte C, Lacroix L, Soria JC. Massard C, et al. Eur J Cancer. 2017 Sep;83:185-193. doi: 10.1016/j.ejca.2017.05.016. Epub 2017 Jul 22. Eur J Cancer. 2017. PMID: 28743036

2

Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer.

Iwata H, Masuda N, Yamamoto D, Sagara Y, Sato N, Yamamoto Y, Saito M, Fujita T, Oura S, Watanabe J, Tsukabe M, Horiguchi K, Hattori S, Matsuura Y, Kuroi K. Iwata H, et al. Breast Cancer Res Treat. 2017 Apr;162(3):501-510. doi: 10.1007/s10549-017-4138-3. Epub 2017 Feb 8. Breast Cancer Res Treat. 2017. PMID: 28181129

3

The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer.

Zhou J, Dong F, Cui F, Xu R, Tang X. Zhou J, et al. Cancer Chemother Pharmacol. 2017 Apr;79(4):825-833. doi: 10.1007/s00280-017-3269-x. Epub 2017 Mar 13. Cancer Chemother Pharmacol. 2017. PMID: 28289866

4

Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib.

Punnoose EA, Atwal S, Liu W, Raja R, Fine BM, Hughes BG, Hicks RJ, Hampton GM, Amler LC, Pirzkall A, Lackner MR. Punnoose EA, et al. Clin Cancer Res. 2012 Apr 15;18(8):2391-401. doi: 10.1158/1078-0432.CCR-11-3148. Epub 2012 Apr 5. Clin Cancer Res. 2012. PMID: 22492982 Clinical Trial.

5

Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.

Mu Z, Wang C, Ye Z, Austin L, Civan J, Hyslop T, Palazzo JP, Jaslow R, Li B, Myers RE, Jiang J, Xing J, Yang H, Cristofanilli M. Mu Z, et al. Breast Cancer Res Treat. 2015 Dec;154(3):563-71. doi: 10.1007/s10549-015-3636-4. Epub 2015 Nov 16. Breast Cancer Res Treat. 2015. PMID: 26573830

6

Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapy.

Aggarwal C, Wang X, Ranganathan A, Torigian D, Troxel A, Evans T, Cohen RB, Vaidya B, Rao C, Connelly M, Vachani A, Langer C, Albelda S. Aggarwal C, et al. Lung Cancer. 2017 Oct;112:118-125. doi: 10.1016/j.lungcan.2017.08.008. Epub 2017 Aug 12. Lung Cancer. 2017. PMID: 29191584

7

Circulating tumor cells as a biomarker predictive of sensitivity to docetaxel chemotherapy in patients with castration-resistant prostate cancer.

Okegawa T, Itaya N, Hara H, Tambo M, Nutahara K. Okegawa T, et al. Anticancer Res. 2014 Nov;34(11):6705-10. Anticancer Res. 2014. PMID: 25368278

8

Baseline circulating tumor cell counts significantly enhance a prognostic score for patients participating in phase I oncology trials.

Olmos D, Baird RD, Yap TA, Massard C, Pope L, Sandhu SK, Attard G, Dukes J, Papadatos-Pastos D, Grainger P, Kaye SB, de Bono JS. Olmos D, et al. Clin Cancer Res. 2011 Aug 1;17(15):5188-96. doi: 10.1158/1078-0432.CCR-10-3019. Epub 2011 Apr 29. Clin Cancer Res. 2011. PMID: 21531820

9

Circulating tumor cells versus objective response assessment predicting survival in metastatic castration-resistant prostate cancer patients treated with docetaxel chemotherapy.

Thalgott M, Heck MM, Eiber M, Souvatzoglou M, Hatzichristodoulou G, Kehl V, Krause BJ, Rack B, Retz M, Gschwend JE, Andergassen U, Nawroth R. Thalgott M, et al. J Cancer Res Clin Oncol. 2015 Aug;141(8):1457-64. doi: 10.1007/s00432-015-1936-z. Epub 2015 Feb 24. J Cancer Res Clin Oncol. 2015. PMID: 25708944 Clinical Trial.

10

Circulating Tumor Cells as an Independent Predictor of Survival in Advanced Gastric Cancer.

Okabe H, Tsunoda S, Hosogi H, Hisamori S, Tanaka E, Tanaka S, Sakai Y. Okabe H, et al. Ann Surg Oncol. 2015 Nov;22(12):3954-61. doi: 10.1245/s10434-015-4483-6. Epub 2015 Mar 17. Ann Surg Oncol. 2015. PMID: 25777087 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

78 results

Results by year